Browse by:
Research & Development

Massachusetts named most innovative state

Bloomberg Business has named Massachusetts as the most innovative state in America, just beating out Silicon Valley and California in the rankings.

AbbVie hepatitis drug granted priority review

Worcester pharmaceutical firm AbbVie has received priority review status from the U.S. Food & Drug Administration for its drug meant to treat those suffering from chronic hepatitis C virus.

Ocata tackles cornea tissue shortage

Sam Bonacci |

Marlborough-based Ocata Therapeutics is moving forward on research that could lead to a steady supply of tissue to treat diseased and injured corneas.

Former GlaxoSmithKline CEO joins Framingham biopharma board

Emily Micucci |

Jean-Pierre Garnier has been appointed chairman of the board of Alzheon Inc., a Framingham-based private biopharmaceutical startup focused on developing treatments for Alzheimer’s...

Ocata results show promise for lupus treatment

Emily Micucci |

Results published in the journal Scientific Reports suggest that Marlborough-based Ocata Therapeutics has developed technology that can be used to prevent lupus nephritis, a fatal...

Copyright 2016 New England Business Media